One woman's lung cancer with a rare gene change responded to ensartinib
Original title: Ensartinib Treatment for Rare Nonclassical ALK Fusion Lung Adenocarcinoma With Brain Metastasis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This drug was used in a real patient, but this is only one person's story.
The short version
A drug called ensartinib helped one woman whose lung cancer had spread to her brain.
What was studied. This is a report about one patient, a 50-year-old woman with lung cancer. Her tests showed a rare gene change. The cancer had also spread to her brain.
What they found. She was given ensartinib along with chemotherapy. Her symptoms got much better, and she gained weight. Scans showed less cancer overall, with no new spots.
What this means, and what it doesn't
What it could mean: For some people with this rare gene change, this drug may help hold the cancer back. It may also reach cancer in the brain. Gene testing is what tells a doctor if a drug like this is an option.
What it doesn't mean: This is one patient's story, not a study of many people. One good result cannot show how well the drug works for others. It is not proof, and it is not a cure. A cancer doctor decides if this drug fits a person's case.
Source: PubMed, September 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.